Trending...
- Putting Your Roses to Bed for Winter in the Deep South - A Gentleman's Guide to Fall Rose Care
- Tens of Thousands Complete Course to Master Entire Bible, Including Revelation
- UK Financial Ltd Unveils The First ERC-3643 Security Token Born from a Meme: Introducing MayaCat Regulated Security Token (SMCAT) Successor to MayaCat
Targeted nutrition for neurodivergent minds—built to fuel strengths, not "fix" differences
CHARLESTON, S.C. - BostonChron -- Unprescribed™ (UNRX) today introduced the Focus, Mood & Mind System™, a three-part nutritional protocol designed to support cognitive performance for neurodivergent minds. Now available at unrx.com, the system includes Daily Focus™, Authentic Mood™, and Core Clarity™—built to fuel strengths rather than "fix" differences.
"Your brain isn't broken—it's specialized hardware running on generalist assumptions," said Allan Stevens, founder of Unprescribed™ and co-founder of the nationwide superfoods brand KOS. "We're not here to make anyone 'normal.' Normal is a setting on a washing machine, not a goal for human consciousness."
Why It's Different
More on Boston Chron
The Focus, Mood & Mind System starts from a simple premise: different wiring often benefits from different inputs. Each formula is designed to support a distinct aspect of everyday mental performance:
Unprescribed™ was sparked by Stevens' personal realization when his daughter received an ADHD diagnosis. "The hyperfocus that built companies and the refusal to think 'normally' drove my best work," he said. "We don't need to be fixed because we're not broken."
The company's manifesto at unrx.com states: "Different isn't disordered. Evolution doesn't make mistakes—it runs experiments. Your wiring isn't an error; it's a variation."
Science-Led Formulation
Unlike mass-market blends designed to be everything to everyone, Unprescribed™ formulations are targeted to common metabolic patterns discussed in the literature—from methylation support to carefully chosen neurotransmitter precursors.* "We don't hide behind proprietary blends," Stevens said. "Every ingredient and dosage is selected based on published research. We're building tools for optimization, not assimilation."
More on Boston Chron
Availability
The Focus, Mood & Mind System is available exclusively at unrx.com. Unprescribed, LLC is headquartered in Charleston, South Carolina. Educational resources, workshops, and advocacy initiatives are planned beginning in 2026.
About Unprescribed
Founded in 2024, Unprescribed™ builds systems for the brilliantly unconventional—combining nutritional protocols, education, and community for people who refuse to be ordinary. Led by Allan Stevens, who previously helped scale KOS to over 130,000 retail distribution points, Unprescribed champions sovereignty over labels and optimization over conformity. Read the manifesto at unrx.com.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
"Your brain isn't broken—it's specialized hardware running on generalist assumptions," said Allan Stevens, founder of Unprescribed™ and co-founder of the nationwide superfoods brand KOS. "We're not here to make anyone 'normal.' Normal is a setting on a washing machine, not a goal for human consciousness."
Why It's Different
More on Boston Chron
- Winzele: A Trusted Isolation Transformer Manufacturer
- Luxury Mediterranean Estate in Gotha Sells for $1.52 Million, Closing $45,000 Over Asking
- ZEELOOL's Black Friday Sale Starts Early with Up to 80% Off Frames
- UV Weathering Test Chamber vs Xenon Arc Test Chamber: What's the Right Solution for Your Products
- Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
The Focus, Mood & Mind System starts from a simple premise: different wiring often benefits from different inputs. Each formula is designed to support a distinct aspect of everyday mental performance:
- Daily Focus™ — Supports attention, working memory, and sustained mental energy.*
- Authentic Mood™ — Supports balanced mood and stress resilience without dulling your edge.*
- Core Clarity™ — Provides a foundational micronutrient base to help address common nutritional gaps.*
Unprescribed™ was sparked by Stevens' personal realization when his daughter received an ADHD diagnosis. "The hyperfocus that built companies and the refusal to think 'normally' drove my best work," he said. "We don't need to be fixed because we're not broken."
The company's manifesto at unrx.com states: "Different isn't disordered. Evolution doesn't make mistakes—it runs experiments. Your wiring isn't an error; it's a variation."
Science-Led Formulation
Unlike mass-market blends designed to be everything to everyone, Unprescribed™ formulations are targeted to common metabolic patterns discussed in the literature—from methylation support to carefully chosen neurotransmitter precursors.* "We don't hide behind proprietary blends," Stevens said. "Every ingredient and dosage is selected based on published research. We're building tools for optimization, not assimilation."
More on Boston Chron
- Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
- 2026 Oscars Betting Odds: One Battle After Another Favored for Best Picture
- City of Boston and Northeastern University Announce New Five-Year PILOT Agreement and New Ten-Year Institutional Master Plan, which include Historic Commitments on Housing and Community Benefits
- Allen Field Co., Inc. Components Selected for Esko ArtiosCAD 3D Component Library
- Boston: Winners Announced For Icons of Franklin Park Poster Competition
Availability
The Focus, Mood & Mind System is available exclusively at unrx.com. Unprescribed, LLC is headquartered in Charleston, South Carolina. Educational resources, workshops, and advocacy initiatives are planned beginning in 2026.
About Unprescribed
Founded in 2024, Unprescribed™ builds systems for the brilliantly unconventional—combining nutritional protocols, education, and community for people who refuse to be ordinary. Led by Allan Stevens, who previously helped scale KOS to over 130,000 retail distribution points, Unprescribed champions sovereignty over labels and optimization over conformity. Read the manifesto at unrx.com.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Source: Unprescribed
Filed Under: Business
0 Comments
Latest on Boston Chron
- Wohler announces three SRT monitoring enhancements for its iVAM2-MPEG monitor and the addition of front panel PID selection of A/V/subtitle streams
- Schemawriter.ai launches WordPress plugin as industry leaders confirm - schema markup is critical
- 20 Million Financing to Accelerate Growth and Advance Digital Asset Strategy Secured for Super League (N A S D A Q: SLE)
- uCAR Trading Launches goldsilbermarkt.de, a New Online Shop for Precious Metals
- Webinar Announcement: Reputational Risk Management in Internal Investigations: Controlling the Narrative Before, During, and After a Crisis
- Taking on the Multi-Billion-Dollar Swipe Industry: AI Curates Who You Meet—IRL over brunch
- 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
- The remaining inventory of antiques from now-closed R. Jorgensen in Maine will be auctioned November 16th in Amesbury, Mass
- Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion
- John McInnis Auctioneers will hold two fine art auctions on Thanksgiving weekend -- November 29 & 30 -- live and online
- Vet Maps Launches National Platform to Spotlight Veteran-Owned Businesses and Causes
- $114.6 Million in Revenues, Up 54%: Uni-Fuels Holdings (N A S D A Q: UFG) Accelerates Global Expansion Across Major Shipping Hubs as Demand Surges
- Dental Care Solutions Unveils New Website for Enhanced Patient Engagement
- TradingHabits.com Launches to Support Day Trader Well-being
- $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
- State Awards Climate Ready Housing Grants to 7 Projects In Boston
- $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
- The Labthink C190H Air Permeability Tester
- BITE Data raises $3m to build AI tools for global trade compliance teams
- Phinge Issues Notice of Possible Infringement, Investigates App-less AI Agents & Technology for Unauthorized Use of its Patented App-less Technologies

